profiles kennedy disease researchers post i wish recognize another researcher carrying baton parsa kazemi esfarjani sc ph researcher department pediatrics division genetics institute genomic medicine school medicine university california san diego author note post little longer normal i want edit point parsa enthusiasm topic lost bruce decide focus research kennedy disease parsa entry kennedy disease community great coincidence master degree candidate i looking lab research program i could learn cutting edge techniques molecular biology genetics program direct relevance human disease i found leonard pinsky lab lady davis institute mcgill university montreal kennedy disease repeat stretch consists amino acid glutamine also called polyglutamine i planning designing experiments deleting various repeat tracts including polyglutamine tract studying affected function androgen receptor cell cultures i came across report journal 'nature al la spada kurt fischbeck colleagues al publication great impetus me ramp work focus notorious polyglutamines len pinsky warn me new discovery would generate great deal interest among scientists high level competition i young daring plunged right fray even though i presently youthful i i believe i still daring past three years i concluded next frontier kennedy disease neurodegenerative disorders exploration safe effective gene therapy system plenty therapeutic candidate genes genetic drug targets nucleic acid protein derivatives rnai systems neuroprotective peptides time put good use properly delivering intended targets bruce briefly summarize currently working feel important kd research parsa i mentioned ultimate long term goal foreseeable future develop effective safe gene therapy could take advantage hundreds candidate therapeutic genes discovered past decade genes discovered remarkable international effort high cost employing genetic screens cell animal disease models yeast worms fruit flies using new bioinformatic tools compare expression thousands genes disease healthy tissues adopting candidate gene approaches cell culture animal models examining genes suspected disease application based prior knowledge however research grant proposal i submitted kennedy disease association also addresses crucial aspect gene cell therapy cell populations tissues contribute toxicity expanded polyglutamine androgen receptor ultimately kennedy disease extent know answer questions redeploy resources develop therapeutic agents vectors appropriate cell tissue targets way shall increase probability positive clinical outcome patients simultaneously reduce odds seeing negative side effects bruce aspirations career goals parsa based guerrilla tactics required make leaps oppose small incremental advances complex field gene therapy neurodegenerative disorders i could asked nurturing positive environment al la spada lab ucsd research faculty i would able devote full attention validating genetic cellular therapeutic targets collaborate colleagues develop long sought systemic gene delivery neurodegenerative disorders kennedy disease establishing effective gene therapy tools strategies would open doors future combinatorial gene therapy improve efficacy safety delivering multiple therapeutic genes gene expressed much lower less toxic level hence less side effects patients continue career line effort time i shall seek well funded position institute superb research infrastructure outstanding colleagues trainees i intellectually engage collaborate bruce strong advocate gene therapy would care comment opportunity parsa respect current state gene delivery central nervous system still fighting great war flying biplanes dropping pound bombs enemy i poylgutamines abetas prions etc al la spada support one missions new theatre research ucsd mobilize collaborative research project among topnotch faculty ucsd affiliates develop advanced gene therapy system new vectors combination viral non viral vector technology could administered intravenously injecting veins opposed intracranially skull intrathecally spinal canal vector carrying therapeutic genetic cargo would distributed cns via microcapillaries across blood brain barrier tremendous amount groundwork already done diverse groups researchers enthusiasm prospects gene therapy geneticists biochemists chemists molecular biologists virologists engineers pathologists etc matter time determination put available technology together create clinically applicable gene delivery systems fact several publications recent years show success systemic gene delivery preclinical research care learn comment i post publications referenced bruce anything else would like mention parsa scientists human face medical research ultimate motivating factor experiments fail funding granted manuscript accepted one simply yearns leave office lab evening join family thoughts families depend research outcome provides mental fuel tougher extra miles